0001289340 2025-01-01 2025-12-31 0001289340 2025-06-30 0001289340 2026-02-28 iso4217:USD shares true FY 0001289340 10-K/A true 2025-12-31 --12-31 2025 false 001-36159 STEREOTAXIS, INC. DE 94-3120386 710 North Tucker Boulevard Suite 110 St. Louis MO 63101 (314) 678-6100 Common Stock, par value $0.001 per share STXS NYSEAMER No No Yes Yes Non-accelerated Filer true false false false false 150300000 97248936 Portions of the Proxy Statement for the registrant’s 2026 Annual Meeting of Shareholders are incorporated by reference in Part III, Items 10, 11, 12, 13 and 14. Stereotaxis, Inc. (“we” or the “Company”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment”) to its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “Original Form 10-K Filing”), which was originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 12, 2026, to include the signature of the Company’s independent registered public accounting firm, Ernst & Young LLP on their audit opinion and Consent (which signatures the Company had obtained as of the date of the Original Form 10-K Filing but which were inadvertently omitted from the filing), and to correct the exhibit number, which was inadvertently filed as Exhibit 22.1. The revised consent by Ernst & Young LLP is filed hereto as Exhibit 23.1.As required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended, new certifications of the Principal Executive Officer and Principal Financial Officer are being filed as exhibits to this Amendment.  Except as expressly set forth herein, this Amendment does not reflect events occurring after the date of the Original Form 10-K Filing or modify or update any of the other disclosures contained therein in any way other than as required to reflect the amendments referred to above. Accordingly, this Amendment should be read in conjunction with the Original Form 10-K Filing and the Company’s other filings with the SEC.